NASDAQ · ATNFW
ETHZilla Corporation Warrant
Healthcare · Medical - Pharmaceuticals
$0.43
Down-$0.03 (-6.52%)
Updated Aug 22, 2026, 11:05 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.6M
- P/E ratio
- -0.19
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 1.62M
- Avg. volume
- 404.02K
Price performance
ATNFW price history
1M range · 0 trading sessions · Daily adjusted prices
ATNFW does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest ATNFW news
The latest Smart Investors Daily articles mentioning ATNFW.
Stock researchCompany · Overview
ATNFW research
Overview
Company profile and research snapshot.
Company profile
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
